Compare Takotsubo and heart attack during early heart scans
Part of Heart & circulation clinical trials.
This trial looks at people with either a heart attack pattern called STEMI or a temporary heart condition called Takotsubo (stress-related heart weakness). It compares what is found during a planned heart artery scan (coronary angiography) within 12 hours, which may help doctors understand and manage these conditions sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have either STEMI (a certain heart attack pattern) or Takotsubo, and doctors plan a heart artery scan within 12 hours of symptom start
- The heart artery scan is scheduled as part of the study plan
- You can sign a written consent form
- You are not in cardiogenic shock (severe condition where the body can’t pump enough blood), sometimes described as Killip class IV
- You expect you can follow the study steps and attend any required visits/tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an optimized medication approach for people diagnosed with Takotsubo (“broken heart”) syndrome. It may help clinicians find a safer and more effective treatment plan after this heart condition.
This trial aims to understand the chemical and physical changes in the heart's blood vessels during Takotsubo syndrome, a temporary heart condition often triggered by stress. It may help doctors better diagnose and treat this condition.
This study uses MRI to learn more about Takotsubo syndrome (a temporary heart condition often triggered by stress). If you have been diagnosed with Takotsubo and have had certain heart tests, you may be able to join.
This trial tests whether giving beta-blockers (medicines that slow the heart and reduce stress) soon after a Takotsubo syndrome diagnosis can improve recovery of heart function. It aims to see if this common heart medication helps people with this specific stress-induced heart condition.
This study enrolls people who have been diagnosed with Takotsubo (a temporary, stress-related heart condition). It aims to better understand Takotsubo by collecting your medical records and analyzing proteins, which may help improve care in the future.
This study examines how certain stem cells (CD34+ cells) may contribute to takotsubo syndrome, a temporary heart condition often triggered by stress. By understanding this connection, researchers hope to improve treatment and recovery for patients with this condition.
Hear when a new Myocardial Stunning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.